98%
921
2 minutes
20
Myocarditis is a life-threatening inflammatory disorder that affects the cardiac muscle tissue. Current treatments merely regulate heart function but fail to tackle the root cause of inflammation. In myocarditis, the initial wave of inflammation is characterized by the presence of neutrophils. Subsequently, neutrophils secrete chemokines and cytokines at the site of heart tissue damage to recruit additional immune cells and regulate defense responses, thereby exacerbating myocarditis. Recent discoveries showing neutrophil extracellular traps (NETs) and their components not only reinforce the proinflammatory functions of neutrophils, inducing enhanced interleukin (IL)-8 secretion, but also induce monocyte/macrophage activation, differentiation, and phagocytic function through the inflammasome pathway. The inflammasome cascade triggers a positive feedback loop through the secretion of proinflammatory cytokines, which leads to further neutrophil activation and degranulation, NET release, monocyte and macrophage infiltration, tissue degradation, and myocardial damage, indicating that neutrophils promote myocarditis-induced cardiac necrosis and an anti-cardiac immune response. In addition, neutrophils can induce oxidative stress and damage cellular structures by releasing excess reactive oxygen species (ROS), thus exacerbating tissue damage in myocarditis. Meanwhile, the recruitment of cells, which is facilitated by neutrophil-secreted chemokines, and the consumption of cells through neutrophil phagocytosis can form a closed loop that continuously maintains a proinflammatory state. This review summarizes the role of neutrophil secretion, phagocytosis and their relationship in myocarditis, and discusses the function of certain agents, such as chemokine antagonists, midkine blockers and neutrophil peptidyl arginine deiminase 4 (PAD4) inhibitors in inhibiting neutrophil secretion and phagocytosis, to provide perspective for myocarditis treatments through the inhibition of neutrophil secretion and phagocytosis.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12415742 | PMC |
http://dx.doi.org/10.31083/RCM39207 | DOI Listing |
Immunity
September 2025
Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria. Electronic address:
In a recent issue of Nature, Adrover et al. report a neutrophil subset that induces pleomorphic tumor necrosis through neutrophil extracellular trap (NET)-mediated vascular occlusion. This process drives epithelial-to-mesenchymal transition (EMT) and metastasis of perinecrotic cancer cells, reframing necrosis as an active process and uncovering targetable mechanisms to combat cancer dissemination.
View Article and Find Full Text PDFNeurol Neuroimmunol Neuroinflamm
November 2025
Department of Neurology, UC Davis Medical Center, Sacramento, CA.
Objectives: Complement factor I (CFI) deficiency is a rare condition that can present with fulminant relapsing CNS autoinflammation. In this report, we highlight the utility of genetic testing in unexplained CNS autoinflammation.
Methods: This case report describes a young adult with partial CFI deficiency, presenting with acute hemorrhagic leukoencephalitis and longitudinally extensive transverse myelitis.
PLoS One
September 2025
Department of Pharmacy, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong Province, China.
Background: Ankylosing spondylitis (AS), a chronic inflammatory disorder affecting axial joints, is frequently complicated by uveitis. However, the molecular mechanisms linking AS to secondary uveitis remain poorly understood.
Methods: We integrated transcriptomic datasets from AS (GSE73754) and uveitis (GSE194060) cohorts to identify shared molecular pathways.
PLoS One
September 2025
Department of Cardiac Surgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Background: Cardiac ischemia reperfusion (I/R) injury is a serious consequence of reperfusion therapy for myocardial infarction (MI). Peptidylarginine deiminase 4 (PAD4) is a calcium-dependent enzyme that catalyzes the citrullination of proteins. In previous studies, PAD4 inhibition protected distinct organs from I/R injury by preventing the formation of neutrophil extracellular traps (NETs) and attenuating inflammatory responses.
View Article and Find Full Text PDFInt J Mol Med
November 2025
Department of Neurosciences 'Rita Levi Montalcini', University of Turin, I‑10125 Turin, Italy.
Kinases are activators of well‑known inflammatory cascades implicated in metabolic disorders, and abnormal activation of casein kinase II (CK2) is associated with several inflammatory disorders. However, thus far, its role in the low‑grade chronic inflammatory response known as 'metaflammation', which is a hallmark of obesity and type 2 diabetes, has not yet been elucidated. The present study aimed to evaluate the role of CK2 in diet‑induced metaflammation and the effects of the CK2 inhibitor 4,5,6,7‑tetrabromobenzotriazole (TBB) on a murine model fed a high‑fat‑high‑sugar (HFHS) diet.
View Article and Find Full Text PDF